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ABSTRACT   
In this work the superficial fluorescence patterns in different nonmelanoma skin cancers and their photodynamic 
treatment response are analysed by a fluorescence based dosimetric model. Results show differences of even more than 
50% in the fluorescence patterns as photodynamic therapy progresses depending on the malignant tissue type.  They 
demonstrate the great relevance of the biological media as an additional dosimetric factor and contribute to the 
development of a future customized therapy with the assistance of dosimetric tools to interpret the fluorescence images 
obtained during the treatment monitoring and the differential photodiagnosis. 
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1. INTRODUCTION  
Photodynamic Therapy (PDT) consists on the administration of a nontoxic drug or dye, known as photosensitizer (PS), 
either systemically or topically. The administration is followed, after an incubation time, by the illumination of the lesion 
with visible light. This leads, in the presence of oxygen, to the generation of cytotoxic agents that produce tissue 
destruction [1]. During the last years it has become widely used in several clinical fields for the treatment of cancer and 
other types of lesions, mainly due to its minimally invasive nature and the use of non ionizing radiation. PDT has been 
increasingly used in dermatology as a therapeutic technique against NonMelanoma Skin Cancer (NMSC) and its 
precursors. The incidence of these last ones has steadily increased over the last decades due to the growth of long term 
exposure to ultraviolet radiation imposed by the current aesthetic tendencies [2]. However, despite the good therapeutic 
response, PDT dosimetry remains a challenging problem. 
Despite the great effort made in recent years, the development of a complete PDT model that considers the entire 
complex phenomena underlying the photodynamic process has not been so far possible. Optical propagation within the 
tissue, PS distribution and photochemical interaction, among other effects, are crucial to evaluate the treatment 
progression and to estimate the treatment outcome for a given clinical context. Furthermore it would be desirable to 
estimate the PS fluorescence, due to the fact that it provides information relative to its degradation during treatment. 
Therefore it could be used as a tool for monitoring the therapy.  
In this work we present a thorough analysis of PDT treatment response and fluorescence monitoring potentialities for 
several common NMSC tumors. The analysis assesses the relevance of the tumor type by employing a three-dimensional 
PDT model. Three types of skin cancer tumors, particularly nodular BCC, infiltrative BCC and squamous cell carcinoma 
(SCC), are considered. The whole photodynamic process is analysed, and superficial radially and depth-resolved 
fluorescence patterns are obtained as the treatment progresses. The specific results for each tumor type could be useful as 
a clinical assistance tool, both for treatment response planning and monitoring. This paper is organized as follows. 
Section 2 describes the dosimetric model for MAL-PDT employed. The analysis of three different types of skin cancer 
tumors is performed in section 3, where the main results are obtained and discussed. Finally section 4 contains the most 
relevant conclusions drawn from the present study.  
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2. DOSIMETRIC MODEL 
The model employed in this work considers the main phenomena in the above mentioned photodynamic process. A brief 
description of the approaches used to model each of them is given below. 
2.1 Topical photosensitizer precursor distribution and accumulation of photoactive agent 
Fick’s law was employed to obtain the inhomogeneous spatial-temporal distribution of the topical PS precursor in the 
target tissue during the 3 hours incubation period imposed by Metvix® protocol. The permeability through the damaged 
stratum corneum in abnormal tissue K and the diffusion coefficient within the tissue D  were taken into account as it is 
expressed in Eq. (1) [3]. In this equation τ  is the relaxation time of the precursor as a consequence of the generation of 
the photosensitizer and other processes such as the lymphatic flow and the blood perfusion, and 0M  is the initial 
concentration of precursor applied in the tumor surface. The initial precursor concentration applied to the tumor surface 
was obtained from the indications given by the protocol specifications related to the Metvix® cream administration, 
assuming a lesion with a circular superficial extension, the precursor density and its molecular mass. The endogenously 
produced photoactive compound 0S  is proportional to the instantaneous value of the precursor concentration when the 
photosensitizer relaxation time pτ  is short compared to its precursor diffusion time t  and can be obtained by Eq. (2). 
Where pε  is the conversion process yield and a pτ →  the relaxation time of the photosensitizer precursor due to the 






t z tK Kz t
Dt D D
o
K K K zM t M e e e erfc t e dt






⎛ ⎞⎛ ⎞′ ′= − +⎜ ⎟⎜ ⎟⎜ ⎟′ ′⎝ ⎠⎝ ⎠
∫
  (1) 








=                                      (2) 
2.2 Photochemical interaction 
The photochemical pathways during a type II PDT process were modeled by a differential equations system (3-8), in 
order to obtain the temporal evolution of the molecular components involved in the photochemical interaction [4, 5].  In 
these equations 0S  is the photosensitizer in ground state whose initial value is that previously obtained after the 
incubation period. 1S  stands for the photosensitizer in singlet excited state and T in triplet excited state. 
3
2O  is the 
oxygen in ground state, 1 2O  is the singlet oxygen, R are the intracellular 
1
2O   receptors and C  the oxygen scavengers;  
1τ  is the relaxation time from state 1S   to 0S ; 3τ  is the relaxation time from state T   to 0S ; 0τ  is the relaxation time 
from state 1 2O  to 
3
2O ; 10η  is the quantum yield of the 1S  to 0S  transition; 13η  is the quantum yield of the 1S  to T  
transition; 30η  is the quantum yield of T  transition to 0S ; 0η  is the quantum yield of 
1
2O transition to 
3
2O ; sα  is the 
efficiency factor for energy transfer from T  to 3 2O ; kpb  stands for the biomolecular photobleaching rate; kcx  is the 
biomolecular cytotoxicity rate; ksc  is the rate of reaction with various oxygen scavengers; ν  is the light speed in tissue; 
ρ  is the photon density; psaσ  is the absorption cross section of  molecules; P  is the rate of oxygen diffusion and 
perfusion; and U  is the cell damage repair rate. The photosensitizer in ground state, whose initial value is that 
previously obtained after the incubation period, is among the required initial conditions to solve it. The stiff differential 
equations system was solved by means of a differential equation solver within the Matlab® platform. 
 
Proc. of SPIE Vol. 9694  96940Z-2
Downloaded From: http://proceedings.spiedigitallibrary.org/ on 03/15/2016 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
 
 
1 30 10 30
0 2 0 1 2
[ ]
[ ] [ ][ ] [ ] [ ] [ ][ ]
1 3 3psa




= − − + + +   (3) 
1
1 0
[ ] 1 [ ] [ ]
1 psa




− + (4) 
330 13
2 1
[ ] [ ] [ ][ ] [ ]
3 3 1









[ ][ ] [ ]
3 0




= − + + (6) 
1
1 1 1 1 302
0 2 2 2 2 2
0
[ ]
[ ][ ] [ ][ ] [ ] [ ] [ ] [ ][ ]
3i




= − − − − + (7) 
1
2
[ ] [ ][ ]d R kcx O R U
dt
= − + (8) 
 
2.2 Propagation of the optical excitation and superficial fluorescence patterns 
Optical modeling in a three-dimensional tissue can be addressed through the Radiation Transport Theory (RTT), 
assuming multiple scattering, and neglecting therefore polarization or interference effects. Without sources inside the 
tissue and in a steady-state situation, the differential RTT can be expressed as in Eq. (9), where the basic parameter of 
light is the specific intensity ˆ( , )I r s or light power per unit area per unit solid angle. The radiation is expected to be at 
point rr , and to follow the direction ŝ . The scattering events are treated according to the scattering phase function 
ˆ ˆ( · ')p s s . Optical radiation comes from direction ŝ′  and is redirected to ŝ . 
4
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The Monte Carlo method by Wang and Jacques [6] was employed to solve it. This implementation is multi-layered, with 
their borders always perpendicular to the laser beam. This assumption is adequate for a stratified media as the skin. The 
approach employs the optical parameters of each tissue layer at the PDT treatment wavelength (635 nm), mainly the 
index of refraction n , the absorption coefficient aμ , the scattering coefficient sμ  and the anisotropy of scattering g  as 
well as its dimensions are required. 
The time-resolved three dimensional PS fluorescence emission at 705 nm was obtained taking into account the excitation 
photon density absorbed by the PS molecules and the fluorescence quantum yield 10η [7]. The temporal evolution of the 
fluorescence power density generated by the PS molecules as the treatment progresses can be expressed as in Eq. (10). In 
this equation ν  is the light speed in tissue, ρ  is the photon density at a point and psaσ  is the absorption cross-section of 




λ=  is the photon energy at the fluorescence emission wavelength emλ , h  is the 
Planck's constant and c  is the speed of light in vacuum. 
0 10( , , ) · · ·[ ]· · emf psa photonP r z t v S E λρ σ η= (10) 
A time-dependent spatially non uniform fluorophore distribution produces time-resolved fluorescence emission sources 
at every spatial position of the tissue sample during the treatment. These sources were considered to obtain the 
fluorescence escape at the tumor surface. Superficial fluorescence due to the PS molecules was calculated by means of 
another Monte Carlo approach [8]. The method was modified to consider local fluorescence sources that are dynamically 
updated over time and space. Thus, for a particular treatment time, the total escaping fluorescence fJ  at a certain 
superficial radial position r  can be obtained by the accumulation of the escaping flux produced by each of the 
fluorescent power sources, as it is expressed in Eq. (11). In this equation sr  and sz  are the coordinates of the 
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fluorescence source, ( , )s sV r zΔ   is the incremental volume associated to the source position, and  ( , , )s sT r z r  is the 
fluorescence transfer function from the source to the tissue surface [9]. 
( , ) ( , , ) ( , ) ( , , )
s s
f f s s s s s s
r z
J r t P r z t V r z T r z r= Δ∑ ∑ (11) 
3. RESULTS AND DISCUSSION 
The MAL-PDT model outlined in the previous section was applied to three different types of NMSC: infiltrative BCC, 
nodular BCC and SCC. The lesion geometry was considered to have a superficial radius of 1 cm and 3 mm depth for all 
of them. Their optical properties at the treatment and fluorescence emission wavelengths were extracted from [10] (see 
table 1), and the same optical source was applied in all the cases. A top hat laser beam with 0.3 cm radius perpendicular 
to the target was used to deliver an irradiance of 100 mW/cm2. The total treatment time was set to 10 minutes. MAL 
initial concentration applied on the surface of the lesion was calculated taking into account the Metvix® clinical protocol 
specifications. This concentration specifies that Metvix® cream is applied in a 1 mm thick layer on the affected area 
covering an extra 5 mm of healthy skin around the damaged area during an incubation period of 3 h before the 
irradiation. Therefore taking into account a MAL density of 160 mg per gram of Metvix® cream and the molecular mass 
of MAL, the initial concentration of the photosensitizer precursor on the pathology surface employed was  4.5·1020 cm-3. 
Common values for the diffusion coefficient through the epidermis and dermis, 0.69 ·10−10 m2⁄s and for the permeability 
of the stratum corneum, 10-6 m/s were adopted. More detailed information related to the values assigned to the 
parameters involved in the photochemical interaction can be found in our previous work [11]. 
 
Table 1. Optical properties of tissues at the treatment and fluorescence emission wavelengths [10]. 
 
Type of tissue Excitation wavelength (635 nm) Emission wavelength (705 nm) μa (cm−1) μs (cm−1) μa (cm−1) μs (cm−1) 
Infiltrative BCC 1.5 142.85 1.5 100 
Nodular BCC 1.5 104.76 0.8 90 
SCC 2 95.238 1 85 
 
Results shown in Fig. 3 reveal differences in the radially-resolved surface fluorescence patterns obtained as the treatment 
progresses depending on the malignant tissue type. Although the spatiotemporal trend was quite similar for the three 
types of skin tumor (nodular BCC, infiltrative BCC and SCC) under the same treatment conditions, fluorescence 
irradiance varies for each lesion at every treatment time (Figs. 3a), b), c) and d)). The statistical quantification of these 
differences within the optical source radius reveals a mean increase (over 50 %) between the nodular BCC and the 
infiltrative BCC during all the treatment time (50.39 % at 60 s, 58.22 % at 300 s and 56.51 % at 600 s). This difference is 
slightly reduced between the SCC and the infiltrative BCC to 35.30 %, 40.62 % and 39.46 % at 60 s, 300 s and 600 s, 
respectively. The discrimination among diseases is considerably reduced when we compare the nodular BCC and the 
SCC.  In this last case, the difference is reduced to 11.18 %, 12.53 % and 12.25 %. This analysis is of great help when 
attempting to monitor the evolution of a personalized treatment. The planning must take into account the particular tumor 
type of the patient, which significantly modifies the fluorescence pattern as shown in the previous results. The 
fluorescence pattern has a direct relationship with the PS degradation during the photochemical interaction, and 
consequently with the cytotoxic agent generation. As it can be appreciated in Fig. 3a), differences are even present at 
only 1·10-8 s from the beginning of the irradiation period, when the cytotoxic agent has not yet been produced. Therefore 
the predictive model used in this work could also be useful as a supporting tool for diagnostic (not treatment-oriented) 
purposes, in what is known as photodynamic diagnosis. The statistically significant differences in the superficial 
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fluorescence emission, as well as the lack of overlap between the standard deviations represented by error bars in Fig. 3, 
support its viability as diagnostic tool. 
 
Figure 3. Surface radially-resolved fluorescence of nodular BCC, infiltrative BCC and SCC malignant tissues (W/cm2) 
vs. the radial component at a) 1·10-8 s, b) 60 s, c) 300 s and d) 600 s. 
4. CONCLUSIONS 
Three different types of NMSC (nodular BCC, infiltrative BCC and SCC) have been analysed by a predictive three-
dimensional time-resolved photochemical and radially-resolved fluorescence model for MAL-PDT. Results reveal 
differences of even more than 50% in the superficial fluorescence patterns obtained as the treatment progresses, 
depending on the type of malignant tissue. Surface fluorescence is related with the cytotoxic effect of the PDT treatment. 
As a consequence the tumor and lesion type of the patient must be considered in the predictive models for appropriate 
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